pandemrix: Clinical Trials

4 trials of pandemrix, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4

Follow pandemrix: new trials by email Literature Review of pandemrix trials Research Report on pandemrix

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Dose Ranging Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' GSK1557484A Vaccine in Children 6 to Less Than 36 Months of Age
Influenza A (H5N1) Virus monovalent vaccine (GSK1557484A). - Influenza
Phase 2CompletedGlaxoSmithKline1852016-07-072019-06-27
Clinical Trial to Evaluate the Immunogenicity and Safety of an Adjuvanted A(H1N1)v Influenza Vaccine and a Non-adjuvanted A(H1N1)v Influenza Vaccine in HIV-infected Patients (ANRS 151 Hifluvac)
adjuvanted A(H1N1)v influenza vaccine, non-adjuvanted A(H1N1)v influenza vaccine - HIV Infections
Phase 2CompletedFrench National Agency for Research on AIDS and Viral Hepatitis3062009-10-012026-04-07
Immunogenicity and Safety of Vaccine GSK2340272A (H1N1) and GSK Biologicals Fluarix™ Vaccine When Co-administered in Elderly
Pandemrix (Influenza vaccine GSK2340272A), Fluarix™, Placebo - Influenza
Phase 2CompletedGlaxoSmithKline1682009-09-122018-08-20
Swine Flu (Novel Influenza A H1N1) Vaccine Study
Baxter Novel Influenza A H1N1 Whole Virus Vaccine, GlaxoSmithKline Novel Influenza A H1N1 Split Virion Vaccine - Influenza
Phase 2CompletedUniversity of Oxford10002009-09-012013-05-09

Conditions studied

Influenza, Human (3)  ·  HIV Infections (1)

Sponsors

GlaxoSmithKline (2)  ·  French National Agency for Research on AIDS and Viral Hepatitis (1)  ·  University of Oxford (1)

Countries

France (1)  ·  Sweden (1)  ·  Taiwan (1)  ·  Thailand (1)  ·  United Kingdom (1)

Top investigators

Adam Finn, PhD, FRCPCH (1)  ·  Andrew Collinson, MRCPCH, MD (1)  ·  Andrew Pollard, MRCP, PhD (1)  ·  Liz Miller, FRCPath, DSc (1)  ·  Matthew Snape, FRCPCH, MD (1)  ·  Odile Launay, MD (1)  ·  Paul Heath, FRCPCH (1)  ·  Saul Faust, MRCPCH, PhD (1)

Results publications

PMID 22885014, PMID 34285165

NIH funding

2009 (1), 2015 (1)